Skip to main content

Security report for ucbpharma.at

UCB Pharma GmbH · Healthcare · Austria

Low risk. 2 critical or high findings in Security headers and SSL/TLS.

Security score

76/100

Risk levelLow

0–100, higher is better. How it is calculated

UCB Pharma GmbH is a global biopharmaceutical company specializing in treatments for neurology, immunology, and internal medicine. The Austrian website serves patients, healthcare professionals, and job seekers with educational content, product information, and corporate details. The site is professionally designed, consistent with the company's global branding, and provides clear navigation and multilingual support. Technically, the website is built on Drupal CMS, leveraging modern JavaScript libraries, Google Tag Manager, and OneTrust for cookie consent, indicating a mature digital infrastructure. Security posture is strong with HTTPS enforced, security headers present, and no visible vulnerabilities. Privacy compliance is well addressed with comprehensive privacy and cookie policies and a consent mechanism. However, WHOIS data is unavailable due to privacy protection, which is common for large corporations. Contact information is limited to a contact form without direct emails or phone numbers. Overall, the website reflects a trustworthy and professional corporate presence with good security and privacy practices.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ucbpharma.at

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
65
Email security
60
DNS health
80
Network security
100
GDPR outside view
83
Average
76

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

UCB Pharma operates in the healthcare sector with a focus on serious diseases in neurology and immunology. The company targets patients and healthcare providers, offering specialized treatments and patient support programs such as the 'Advantage Hers' campaign. The business model centers on research, development, and commercialization of pharmaceutical products. The website's multilingual and global navigation options indicate a broad international presence. The company maintains active social media channels to engage with stakeholders. The lack of direct contact details suggests a controlled communication strategy. The website content and structure support a large enterprise with a strong market position in biopharma.

Security posture

The website demonstrates a solid security posture with HTTPS enabled and standard security headers implemented. Cookie consent is managed via OneTrust, ensuring GDPR compliance. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of explicit security policies, incident response information, and vulnerability disclosure mechanisms indicates areas for improvement. The site uses trusted third-party analytics and tracking services, but continuous monitoring of these is recommended to mitigate supply chain risks. Overall, the security maturity is good but could be enhanced by publishing security policies and incident response contacts.

Recommendations

  1. Publish a security.txt file to facilitate vulnerability reporting and improve transparency.
  2. Add an incident response policy page with clear contact channels for security issues.
  3. Create and publish a terms of service page to clarify user agreements and legal terms.
  4. Enhance contact information by providing verified company emails and phone numbers for support and inquiries.
  5. Regularly audit and update third-party scripts and tracking tools to minimize security risks.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
UCB Pharma GmbH
Description
UCB ist ein weltweit tätiges biopharmazeutisches Unternehmen, das sich auf Erkrankungen in den Bereichen Neurologie, Immunologie und der Inneren Medizin fokussiert.
Key services
Neurology treatments, Immunology treatments, Internal medicine treatments, Patient education, Job opportunities
Content quality
good
Branding
consistent

Technology

Stack
Drupal CMS, JavaScript, OneTrust Cookie Consent, Google Tag Manager, Vimeo Player API
Frameworks
Drupal
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML
  • Secure forms with CSRF tokens (implied by Drupal)

Analytics and tracking

Services
Siteimprove Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Siteimprove Analytics
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Content is professional, focused on healthcare and patient education.
  3. Strong privacy and cookie consent mechanisms implemented.
  4. WHOIS data is unavailable, likely due to privacy protection.
  5. No direct company emails or phone numbers found; contact via form only.
  6. Multiple social media channels linked, indicating active engagement.
  7. No explicit security.txt or incident response info found.
  8. No terms of service page detected.
  9. Website uses Drupal CMS with modern tracking and consent tools.
Technical notes

Notes

The website is built on Drupal CMS, a robust and widely used content management system suitable for enterprise websites. It uses modern JavaScript libraries and integrates OneTrust for cookie consent management and Google Tag Manager for analytics. The site is mobile-optimized and accessible, with good SEO practices evident from meta tags and structured navigation. Performance is moderate, with asynchronous loading of scripts and lazy loading of images. No hosting provider details were identified from the content. The technical stack supports scalability and compliance but should be regularly maintained to address emerging security and performance challenges.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ucbpharma.at. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ucbpharma.at.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.